Electrosurgical Interference with Patient Monitoring in Theatre 3
In a district general hospital day-surgery unit, a newly installed electrosurgical unit (ESU, 400 W monopolar, 350 kHz) in Theatre 3 coincides with baseline wander on ECG Lead II and spurious NIBP readings of 60/30 mmHg during a laparoscopic cholecystectomy. The anaesthetist notes the SpO2 plethysmograph looks normal and the patient is clinically stable. Your team measures earth leakage current of the theatre equipment stack at 460 uA in normal condition, and patient leakage current on the ECG module at 8 uA (type CF, at 50 Hz). The ESU return electrode is a split-pad type on the right thigh; the ECG lead wires are 1.2 m long and run parallel to the ESU cable for about 2 m. The theatre is fed from a medical IT system with a line isolation monitor. It is 14:20 and three cases remain on the list.
1. Do the leakage current measurements indicate an electrical safety hazard? Interpret them against IEC 60601-1 and identify the likely coupling mechanism.
Read the worked answer
The measurements are within limits but leave little margin, and they do not explain the artefact.
- Earth leakage, 460 uA. The IEC 60601-1 normal-condition limit is 500 uA for Class I permanently connected and non-permanently connected equipment; 460 uA passes but is close to the limit. Re-measure in single-fault condition, check whether the value is the stack sum or per device, and check the IT system and line isolation monitor readings. A high normal-condition reading suggests aging insulation, a switched-mode supply leak or a faulty mains filter - worth an investigation, but not an immediate patient hazard.
- Patient leakage, 8 uA at 50 Hz. The type CF limit in normal condition is 10 uA, so again it passes with little margin and must be rechecked in single-fault condition and after the ESU is disconnected. This is a low-frequency measurement; it says nothing about current at 350 kHz.
- The likely mechanism is high-frequency interference, not LF leakage. The ESU cables and the ECG leads run parallel over 2 m, giving capacitive and inductive coupling; the patient forms part of a common-mode circuit. The monitor's input amplifier is being driven out of its common-mode range, producing baseline wander, while the NIBP module's pressure transducer or pump control is disturbed. Poor return-electrode contact raises the HF voltage on the patient and worsens everything.
- Do not conflate the two issues. A pass on leakage testing does not clear an EMC problem, and an EMC fix does not excuse a 460 uA reading.
2. What do you do during the remaining list, and do you stop surgery?
Read the worked answer
The clinical risk is misinterpretation, not electrocution; manage the monitor, not the schedule.
- Do not cancel on electrical-safety grounds. The patient is stable, the SpO2 is plausible, and the leakage values are within limits. Cancelling would expose the patient to a second anaesthetic for no clear gain.
- Immediate actions, in order:
- Confirm the patient's status clinically and with a manual blood pressure if NIBP is unreliable.
- Re-site or re-check the return electrode - dry, hairless, muscular area, full contact, split-pad correctly positioned and plugged in; increase contact quality.
- Re-route the ECG leads away from the ESU cable, cross at right angles where movement is unavoidable, and shorten the lead run.
- Enable the monitor's ESU artefact-suppression filter or blanking, and verify which ECG filter is active; a 50/60 Hz notch filter does nothing at 350 kHz.
- Ask the surgeon to use the lowest effective power and bipolar where clinically acceptable.
- Document the actions and the times in the anaesthetic record.
- Escalate if the ECG becomes uninterpretable for arrhythmia detection, the SpO2 or invasive pressures also degrade, or the line isolation monitor alarms. In that case, stop and convert to an alternative monitoring configuration.
- After the list, take Theatre 3 off the schedule until the EMC issue is characterised, and inform the theatre manager the same day.
3. What engineering follow-up and longer-term controls would you put in place?
Read the worked answer
Treat this as an EMC and procurement problem with an incident-reporting component.
- Investigate systematically. Reproduce with a phantom or test load: ESU activation at various power settings with the monitor connected, measuring artefact amplitude against cable separation, filter setting and return-electrode impedance. Record which combination produces acceptable traces.
- Verify compliance. Confirm both devices carry current IEC 60601-1-2 evidence and check the manufacturer's stated separation distances and recommended cable routing. The ESU is an intentional HF emitter; the monitor must be immune to the expected field, and the installation must respect both sets of instructions.
- Installation controls. Fixed cable trunks with physical separation, dedicated socket outlets, ESU and monitor on the same IT system but not sharing a multi-socket strip, and a routine pre-list check added to the theatre checklist.
- Procurement. Add a requirement that any new monitor in an ESU-equipped theatre demonstrates artefact rejection during ESU activation at the specified separation. Evaluate as a system, not device by device.
- Report. File an internal incident report (near-miss or no-harm event) and consider a user report to MDD under MDACS if the monitor's performance is judged not to meet its claims; the supplier should be asked for a technical opinion in writing.
- Training. Anaesthetists and theatre practitioners should recognise ESU artefact, know the filter options, and know that a normal plethysmograph with an abnormal ECG is a monitoring problem until proven otherwise.